Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Blast Crisis × nilotinib × Clear all

Status

Approved for marketing 1

Sponsor Class

Study Type

Interventional 6 Expanded_access 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Blast Crisis 1

Interventions

nilotinib 1 fludarabine phosphate 1 Whole-Body Irradiation 1 Tacrolimus 1 Mycophenolic Acid 1 Cytarabine 1 Cord Blood Stem Cell Transplantation 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00905593 2012-07-18

ENACT

Novartis

Approved for marketing

MyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡